Table 1.
Baseline patient characteristics
| Recovered (n=191) | Control cohort (n=4529) | P value | |
|---|---|---|---|
| Baseline Characteristics | |||
| Age (Mean ± SD) | 63 yr ± 12.0 | 69.1 ± 11.5 | 0.0012 |
| Male sex - no. (%) | 74.9% (143/191) | 67.1% (3039/4529) | <0.0001 |
| Black, Asian, Minority Ethnic - no. (%) | 52.9% (101/191) | 35.6% (1612/4529) | <0.0001 |
| Median BMI (IQR) | 27.4 (24.7:31.1) | 28.0 (26.1:29.9) | 0.058 |
| Past Medical History - no. (%) | |||
| Hypertension | 60.2% (115/191) | 56.1% (2541/4529) | <0.0001 |
| Hypercholesterolemia | 64.9% (124/191) | 40.7% (1843/4529) | <0.0001 |
| Diabetes mellitus | 40.8% (78/191) | 36.4% (1649/4529) | 0.0013 |
| Smoking history | 44.0% (84/191) | 25.3% (1146/4529) | <0.0001 |
| Previous MI | 44.0% (84/191) | 33.6% (1522/4529) | <0.0001 |
| Previous PCI | 37.2% (71/191) | 27.4% (1241/4529) | <0.0001 |
| Median GRACE score | 128 (86:153) | 135 (105:169) | 0.106 |
| Median laboratory values (IQR)- at time of procedure | |||
| Troponin T - ng/L (initial COVID diagnosis/referral) | 111.5 (54:455) | 135 (64:745) | <0.0001 |
| Troponin T - ng/L (at time of procedure) | 27 (16:151) | NA | |
| White-cell count - 109/L | 8.3 (6.9:10.2) | 7.5 (5.8:9.2) | 0.077 |
| Lymphocyte count - 109/L | 1.8 (1.4:2.3) | 2.1 (1.7:2.6) | 0.069 |
| LDH - unit/L | 229 (199:250) | 145 (124:223) | 0.053 |
| D-Dimer - mg/L (0-0.5) | 0.3 (0.3:0.7) | 0.2 (0.1:0.4) | 0.112 |
| Fibrinogen - g/L | 1.65 (0.55:5.04) | 1.41 (1.02:2.69) | 0.104 |
| Ferritin - ug/L (30-400) | 202 (84:263) | 189 (131:287) | 0.005 |
| Creatinine - umol/L | 81 (69:98) | 77 (70:88) | 0.230 |
| Creatine kinase (CK) - u/L | 85 (58:130) | 81 (68:113) | 0.398 |
| C-reactive protein (CRP) - mg/L | 4 (2:8) | 3 (1:5) | 0.276 |